Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedMar 22, 2023
DataAggregated Company Financials
  • 7D1.8%
  • 3M13.0%
  • 1Y-17.4%
  • YTD11.2%

Over the last 7 days, the Life Sciences industry has risen 2.1%, driven by gains from Lonza Group of 1.8%. In the past year, the industry is down 18%. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 22 Mar 2023CHF56.4bCHF9.7bCHF1.7b41.5x34x5.8x
Fri, 17 Feb 2023CHF58.0bCHF9.6bCHF1.6b33.9x35.5x6.1x
Sun, 15 Jan 2023CHF53.4bCHF9.2bCHF1.3b40x40.2x5.8x
Tue, 13 Dec 2022CHF51.3bCHF9.2bCHF1.3b37.8x38.6x5.6x
Thu, 10 Nov 2022CHF54.6bCHF9.2bCHF1.3b42.1x41.1x5.9x
Sat, 08 Oct 2022CHF51.4bCHF9.2bCHF1.3b40.7x39.8x5.6x
Mon, 05 Sep 2022CHF54.4bCHF9.2bCHF1.3b42.5x42.1x5.9x
Wed, 03 Aug 2022CHF57.6bCHF8.9bCHF1.3b35.1x43.9x6.5x
Fri, 01 Jul 2022CHF52.3bCHF8.5bCHF1.1b42.7x48.5x6.2x
Sun, 29 May 2022CHF58.5bCHF8.5bCHF1.1b47.4x54.2x6.9x
Tue, 26 Apr 2022CHF61.9bCHF8.5bCHF1.1b56.6x57.4x7.3x
Thu, 24 Mar 2022CHF68.1bCHF8.3bCHF1.1b50.6x63.1x8.2x
Sat, 19 Feb 2022CHF63.8bCHF8.0bCHF1.1b50x59.7x8x
Mon, 17 Jan 2022CHF69.6bCHF7.4bCHF929.4m72.6x74.9x9.4x
Wed, 15 Dec 2021CHF77.3bCHF7.4bCHF918.2m85.4x84.2x10.5x
Fri, 12 Nov 2021CHF78.6bCHF7.4bCHF918.9m71.3x85.5x10.7x
Sun, 10 Oct 2021CHF75.4bCHF7.4bCHF919.7m70.3x82x10.2x
Tue, 07 Sep 2021CHF82.7bCHF7.4bCHF920.8m87.5x89.9x11.2x
Thu, 05 Aug 2021CHF75.4bCHF7.4bCHF920.8m61.8x81.9x10.2x
Sun, 09 May 2021CHF61.1bCHF7.1bCHF964.3m60.5x63.4x8.7x
Wed, 10 Feb 2021CHF55.2bCHF6.5bCHF972.6m53.9x56.7x8.5x
Tue, 03 Nov 2020CHF54.0bCHF5.4bCHF913.9m57.3x59.1x10x
Fri, 07 Aug 2020CHF52.6bCHF5.3bCHF889.3m56.1x59.2x9.9x
Thu, 30 Apr 2020CHF40.0bCHF5.6bCHF858.4m47x46.6x7.1x
Price to Earnings Ratio


Total Market Cap: CHF37.7bTotal Earnings: CHF858.4mTotal Revenue: CHF5.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 58.1x202120222023
Current Industry PE
  • Investors are pessimistic on the Swiss Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 34.0x which is lower than its 3-year average PE of 58.1x.
  • The 3-year average PS ratio of 8.2x is higher than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.63%
Life Sciences1.83%
Clinical Research and Equipment1.83%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LONN Lonza GroupCHF536.202.6%
TECN Tecan GroupCHF394.802.3%
SKAN SKAN GroupCHF69.506.6%
SFZN Siegfried HoldingCHF649.500.7%
XLS Xlife SciencesCHF33.502.4%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.